3320 — China Resources Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapSuper Stock

Annual balance sheet for China Resources Pharmaceutical, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	34,789	38,587	47,067	46,522	59,266
Net Total Accounts Receivable
Net Total Receivables	56,662	55,927	62,772	67,872	75,572
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	118,809	123,819	143,903	152,259	178,568
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,754	19,266	20,804	22,092	25,376
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	169,822	176,225	202,531	215,534	246,770
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	95,331	103,207	115,151	121,770	134,233
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	133,439	137,112	160,991	171,977	200,811
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	36,383	39,113	41,540	43,557	45,960
Total Liabilities & Shareholders' Equity	169,822	176,225	202,531	215,534	246,770
Total Common Shares Outstanding